Rural-urban differences in out-of-network treatment initiation and engagement rates for substance use disorders
- PMID: 38456488
- PMCID: PMC11366955
- DOI: 10.1111/1475-6773.14299
Rural-urban differences in out-of-network treatment initiation and engagement rates for substance use disorders
Abstract
Objective: To examine rural-urban disparities in substance use disorder treatment access and continuation.
Data sources and study setting: We analyzed a 2016-2018 U.S. national secondary dataset of commercial insurance claims.
Study design: This cross-sectional study examined individuals with a new episode of opioid, alcohol, or other drug use disorders. Treatment initiation and engagement rates, and rates of using out-of-network providers for these services, were compared between rural and urban patients.
Data collection: We included individuals 18-64 years old with continuous employer-sponsored insurance.
Principal findings: Patients in rural settings experienced lower treatment initiation rates for alcohol (36.6% vs. 38.0%, p < 0.001), opioid (41.2% vs. 44.2%, p < 0.001), and other drug (37.7% vs. 40.1%, p < 0.001) use disorders, relative to those in urban areas. Similarly, rural patients had lower treatment engagement rates for alcohol (15.1% vs. 17.3%, p < 0.001), opioid (21.0% vs. 22.6%, p < 0.001), and other drug (15.5% vs. 17.5%, p < 0.001) use disorders. Rural patients had higher out-of-network rates for treatment initiation for other drug use disorders (20.4% vs. 17.2%, p < 0.001), and for treatment engagement for alcohol (27.6% vs. 25.2%, p = 0.006) and other drug (36.1% vs. 31.1%, p < 0.001) use disorders.
Conclusions: These findings indicate that individuals with substance use disorders in rural areas have lower rates of initial and ongoing treatment, and are more likely to seek care out-of-network.
Keywords: alcohol‐related disorders; managed care programs; opioid‐related disorders; provider networks; rural health services; substance‐related disorders.
© 2024 The Authors. Health Services Research published by Wiley Periodicals LLC on behalf of Health Research and Educational Trust.
Conflict of interest statement
Dr. Retchin reports fees and stock options from Aveanna Healthcare as an independent director, outside the submitted work. Dr. Carlo reports consulting fees from Otsuka Pharmaceutical, and honoraria from the Mid‐America Mental Health Technology Transfer Center, outside the submitted work. Drs. Raver, Li, and Xu have nothing to disclose.
References
-
- Substance Abuse and Mental Health Services Administration . Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2021. https://www.samhsa.gov/data/
-
- Saunders H, Rudowitz R. Demographics and Health Insurance Coverage of Nonelderly Adults with Mental Illness and Substance Use Disorders in 2020. Kaiser Family Foundation; 2022. https://www.kff.org/medicaid/issue‐brief/demographics‐and‐health‐insuran...
-
- National Institute on Drug Abuse . Overdose death rates. 2022. https://nida.nih.gov/research‐topics/trends‐statistics/overdose‐death‐rates
-
- Spencer MR, Curtin SC, Hedegaard H. Rates of alcohol‐induced deaths among adults aged 25 and over in urban and rural areas: United States, 2000–2018. NCHS Data Brief. 2020;383:1‐8. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
